IHTC NEWS:
09.11.2010 - Sickle Cell-abration 2010
The IHTC is sponsoring a free concert to raise awareness of sickle cell disease! Come and enjoy a diverse blend of music at the Madame Walker Theater. The free concert is from 5 to 9 pm; doors open at 4:30 pm. You may also choose to share the gift of life with those who have sickle cell disease by...
04.20.2010 - IHTC voted one of Indiana's best workplaces!
As reported in the IndyStar, over 600 companies in central Indiana were invited by Workplace Dynamics of Exton, PA, to participate in a workplace survey in January 2010. Nearly 20,000 employees from 101 large, middle, and small companies voted on their workplace management,...
Disease & Care Management
Disease & Care Management
The bleeding disorders Disease Management Program (DMP) of the Indiana Hemophilia & Thrombosis Center (IHTC) is designed to effectively contain the overall cost of care while improving health outcomes for patients with bleeding disorders who participate in the program. The key goals of the program include:
- Cost containment
- Reduction in bleeding events
- Reduction in resource utilization
- Fewer inpatient hospital days / unplanned hospitalizations
- Fewer emergency room visits
- Decreased clotting factor utilization
- Improvement in functional status with equal or improved quality of life
The program components include:
- A free annual comprehensive clinic evaluation with the IHTC multidisciplinary team
- An annual knowledge assessment to measure participants’ general knowledge of their condition, complications of bleeding disorders, dental and oral care, physical activity, home therapy, and infection control
- Educational initiatives to enhance participant knowledge of bleeding disorders and address gaps identified through the knowledge assessment. Education is provided through newsletters, one-on-one sessions and provision of additional material
- Close ongoing contact through telephone, email and home visits to discuss health issues and concerns, educational needs, adherence to treatment, bleeding episodes; and to coordinate scheduling of appointments as needed to assess current/ongoing conditions
- Dispensation of clotting factor concentrate through a qualified Public Health Service 340B vendor; with all prescriptions for clotting factor concentrate written and signed by IHTC physicians
- Utilization of a web-based electronic treatment and infusion log system to track and monitor bleeding events and administered treatment
- Regularly scheduled meetings among the IHTC DMP team and clinical staff
The IHTC DMP components can be tailored to meet the specific needs of the payors and is cost effective for any size population.
The IHTC DMP began in 2004 and has documented substantial cost savings each year since. Relative to the baseline measurement (the year prior to institution of the DMP), the 4-year (Oct 2004-Sept 2008) average improvements in mean outcomes include the following†:
- 22.4% reduction in per-member, per-month costs
- 72.0% reduction in outpatient medical costs
- 36.6% reduction in hospital costs
- 20.8% reduction in outpatient clotting factor costs
- 58.9% reduction in number of emergency room visits
- 17.5% reduction in number of inpatient hospital days
Five years after implementation, the total savings of the IHTC DMP are estimated to exceed $5.8 million.
The initial results of IHTC’s DMP model were published in a leading, peer-reviewed hemophilia journal. To read the abstract, please click here.
†Data extrapolated from IHTC DMP Year 4 Progress Report. Contact Natalie Duncan for more information.
